location: Current position: Home-Yong Liu >> Scientific Research >> Paper Publications

Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases.

Hits:

Date of Publication:2024-05-26

Journal:Toxicology in vitro : an international journal published in association with BIBRA

Volume:92

Page Number:105664

ISSN No.:0887-2333

Key Words:Drug-drug interaction; Ponatinib; Tyrosine kinase inhibitor; UDP-glucuronosyltransferases

Pre One:Higher risk of hepatotoxicity associated with cabozantinib in cancer patients

Next One:Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1 In vitro.